Global private equity and venture capital news and research

Posts Tagged ‘Hopen Life Science Ventures’

22 April 2014

Vivo Capital leads $58.5m Series D for ProNAi Therapeutics

biotech_lrg Nucleic acid therapeutics developer ProNAi Therapeutics has secured $59.5m in a Series D round led by venture capital firm Vivo Capital.

6 March 2013

Hopen still short of $50m fund target after more than two years on roadp

Hopen Life Science Ventures is continuing to fundraise for its second investment vehicle more than a year after it expected to hold a $50m final close.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015